Remicade (infliximab), a new biotech drug for Crohn's disease
Centocor will market Remicade (infliximab), a new biotech drug for Crohn's disease.
It's a monoclonal antibody that neutralizes the activity of tumor necrosis factor...a protein that promotes inflammation.
Remicade is also being tested for other inflammatory conditions such as rheumatoid arthritis.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote